AAAAAA

   
Results: 1-7 |
Results: 7
A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor : receptor complex
Authors: Cooke, SP Boxer, GM Lawrence, L Pedley, RB Spencer, DIR Begent, RHJ Chester, KA
Citation: Sp. Cooke et al., A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor : receptor complex, CANCER RES, 61(9), 2001, pp. 3653-3659
Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody
Authors: Mayer, A Tsiompanou, E O'Malley, D Boxer, GM Bhatia, J Flynn, AA Chester, KA Davidson, BR Lewis, AAM Winslet, MC Dhillon, AP Hilson, AJW Begent, RHJ
Citation: A. Mayer et al., Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody, CLIN CANC R, 6(5), 2000, pp. 1711-1719
Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer
Authors: Chester, KA Mayer, A Bhatia, J Robson, L Spencer, DIR Cooke, SP Flynn, AA Sharma, SK Boxer, G Pedley, RB Begent, RHJ
Citation: Ka. Chester et al., Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer, CANC CHEMOT, 46, 2000, pp. S8-S12
Clinical applications of phage-derived sFvs and sFv fusion proteins
Authors: Chester, KA Bhatia, J Boxer, G Cooke, SP Flynn, AA Huhalov, A Mayer, A Pedley, RB Robson, L Sharma, SK Spencer, DIR Begent, RHJ
Citation: Ka. Chester et al., Clinical applications of phage-derived sFvs and sFv fusion proteins, DIS MARKER, 16(1-2), 2000, pp. 53-62
Crystal structure of the anti-(carcinoembryonic antigen) single-chain Fv antibody MFE-23 and a model for antigen binding based on intermolecular contacts
Authors: Boehm, MK Corper, AL Wan, T Sohi, MK Sutton, BJ Thornton, JD Keep, PA Chester, KA Begent, RHJ Perkins, SJ
Citation: Mk. Boehm et al., Crystal structure of the anti-(carcinoembryonic antigen) single-chain Fv antibody MFE-23 and a model for antigen binding based on intermolecular contacts, BIOCHEM J, 346, 2000, pp. 519-528
Catalytic activity of an in vivo tumor targeted anti-CEA scFv :: carboxypeptidase G2 fusion protein
Authors: Bhatia, J Sharma, SK Chester, KA Pedley, RB Boden, RW Read, DA Boxer, GM Michael, NP Begent, RHJ
Citation: J. Bhatia et al., Catalytic activity of an in vivo tumor targeted anti-CEA scFv :: carboxypeptidase G2 fusion protein, INT J CANC, 85(4), 2000, pp. 571-577
Taking engineered anti-CEA antibodies to the clinic
Authors: Mayer, A Chester, KA Flynn, AA Begent, RHJ
Citation: A. Mayer et al., Taking engineered anti-CEA antibodies to the clinic, J IMMUNOL M, 231(1-2), 1999, pp. 261-273
Risultati: 1-7 |